Zampilimab, identified as UCB-7858 or 2098280-42-1, represents a innovative therapeutic agent targeting TGM2, a molecule involved in fat metabolism and possibly implicated in multiple inflammatory https://www.targetmol.com/compound/zampilimab
Zampilimab: A In-depth Analysis into the TGM2 Protein (UCB-7858, 2098280-42-1)
Internet - 2 hours 39 minutes ago anyalznj024471
Web Directory Categories
Web Directory Search
New Site Listings